BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 1901889)

  • 1. Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72.
    Irvine K; Schlom J
    Cancer Immunol Immunother; 1993 May; 36(5):281-92. PubMed ID: 7682893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological properties of a single-chain fragment of the anti-idiotypic antibody ACA125.
    Reinartz S; Wagner U; Giffels P; Gruenn U; Schlebusch H; Wallwiener D
    Cancer Immunol Immunother; 2000 Jul; 49(4-5):186-92. PubMed ID: 10941901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiotype vaccine for tumor by anti-idiotypic antibody prepared against anti-(bacillus Calmette Guèrin)BCG monoclonal antibody.
    Sasaki J; Tamagake T; Narita S; Ahsan CR
    Cancer Immunol Immunother; 1990; 31(5):273-7. PubMed ID: 2198089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 ganglioside.
    Basak S; Birebent B; Purev E; Somasundaram R; Maruyama H; Zaloudik J; Swoboda R; Strittmatter W; Li W; Luckenbach A; Song H; Li J; Sproesser K; Guerry D; Nair S; Furukawa K; Herlyn D
    Cancer Immunol Immunother; 2003 Mar; 52(3):145-54. PubMed ID: 12649743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor idiotype vaccines. VIII. Analysis of protective idiotype in sera and hybridomas derived from tumor-bearing mice with long-term survival.
    Chen JJ; Kohler H
    Cancer Immunol Immunother; 1993 Nov; 37(6):373-7. PubMed ID: 8242662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic studies of radiolabelled rat monoclonal antibodies recognising syngeneic sarcoma antigens. I. Comparison of IgG subclasses.
    Eccles SA; Purvies HP; Styles JM; Hobbs SM; Dean CJ
    Cancer Immunol Immunother; 1989; 30(1):5-12. PubMed ID: 2598175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of T suppressor factors from tumour-bearing mice and mice immunized with a monoclonal anti-idiotypic antibody.
    Greer JM; Halliday WJ
    Cancer Immunol Immunother; 1990; 31(3):151-6. PubMed ID: 2110863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological and histopathological changes in sheep affected with cutaneous squamous cell carcinoma and treated immunotherapeutically.
    Abo-Aziza FAM; Zaki AA; El-Shemy A; Elhalem SSA; Amer AS
    Vet World; 2017 Sep; 10(9):1094-1103. PubMed ID: 29062199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-idiotype and recombinant antigen in immunotherapy of colorectal cancer.
    Herlyn D; Somasundaram R; Zaloudik J; Jacob L; Harris D; Kieny MP; Sears H; Mastrangelo M
    Cell Biophys; 1994; 24-25():143-53. PubMed ID: 7736518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-idiotype cancer vaccines: past and future.
    Herlyn D; Somasundaram R; Li W; Maruyama H
    Cancer Immunol Immunother; 1996 Oct; 43(2):65-76. PubMed ID: 8954140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of syngeneic rat monoclonal antibodies to the HSN tumor using syngeneic monoclonal anti-idiotopic antibodies.
    Léger O; Dean CJ
    J Immunol; 1991 Apr; 146(8):2879-86. PubMed ID: 1901889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine monoclonal anti-idiotype antibody as a potential network antigen for human carcinoembryonic antigen.
    Bhattacharya-Chatterjee M; Mukerjee S; Biddle W; Foon KA; Köhler H
    J Immunol; 1990 Oct; 145(8):2758-65. PubMed ID: 1698862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II (AII)-related idiotypic network. II. Heterogeneity and fine specificity of AII internal images analyzed with monoclonal antibodies.
    Budisavljevic M; Geniteau-Legendre M; Baudouin B; Pontillon F; Verroust PJ; Ronco PM
    J Immunol; 1988 May; 140(9):3059-65. PubMed ID: 2452197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiotype vaccines against human T cell acute lymphoblastic leukemia. I. Generation and characterization of biologically active monoclonal anti-idiotopes.
    Bhattacharya-Chatterjee M; Pride MW; Seon BK; Kohler H
    J Immunol; 1987 Aug; 139(4):1354-60. PubMed ID: 3497200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiotype vaccines against human T cell leukemia. II. Generation and characterization of a monoclonal idiotype cascade (Ab1, Ab2, and Ab3).
    Bhattacharya-Chatterjee M; Chatterjee SK; Vasile S; Seon BK; Kohler H
    J Immunol; 1988 Aug; 141(4):1398-403. PubMed ID: 2899603
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.